CureMatch has a total of 18 patents globally, out of which 1 have been granted. Of these 18 patents, more than 55% patents are active. The United States of America is where CureMatch has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of CureMatch.
CureMatch was founded in 2015. CureMatch is a digital health enterprise specializing in oncology medicine and combination therapy. Additionally, CureMatch provides data-driven support systems for cancer treatment tailored to each patient’s tumor profile.
Do read about some of the most popular patents of CureMatch which have been covered by us in this article and also you can find CureMatch patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over CureMatch patent portfolio.
How many patents does CureMatch have?
CureMatch has a total of 18 patents globally. These patents belong to 4 unique patent families. Out of 18 patents, 10 patents are active.
How Many Patents did CureMatch File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | CureMatch Applications Filed | CureMatch Patents Granted |
| 2022 | 2 | 1 |
| 2020 | 2 | – |
| 2019 | 1 | – |
| 2018 | 10 | – |
| 2017 | 3 | – |
How many CureMatch patents are Alive/Dead?
Worldwide Patents
How Many Patents did CureMatch File in Different Countries?
Countries in which CureMatch Filed Patents
| Country | Patent |
| United States Of America | 4 |
| Europe | 3 |
| Canada | 2 |
| Mexico | 2 |
| Korea (South) | 1 |
| Hong Kong (S.A.R.) | 1 |
| Japan | 1 |
Where are Research Centers of CureMatch Patents Located?
The Research Center of CureMatch is located in United States of America.
What Percentage of CureMatch US Patent Applications Were Granted?
CureMatch (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of CureMatch patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for CureMatch?
| Law Firm | Total Applications | Success Rate |
| Torrey Pines Law Group Pc | 1 | 100% |
List of CureMatch patents
| CureMatch Patents | Title |
| US11434534B2 | Optimizing Therapeutic Options In Personalized Medicine |
| US20230073255A1 | Optimizing Therapeutic Options In Personalized Medicine |
| EP3510175A4 | Optimizing Therapeutic Options In Personalized Medicine |
| WO2023097300A1 | Clinical Trial Optimization |
| MX2020001610A | Drug Combinations For Targeting Multiple Mutations In Cancer. |
| MX2019002731A | Optimizing Therapeutic Options In Personalized Medicine. |
| CA3076918A1 | Method Of Prediction Of Tumor-Derived Neo-Peptide Antigenicity And/Or Immunogenicity Using Mutational Signature Patterns |
| CA3072345A1 | Drug Combinations For Targeting Multiple Mutations In Cancer |
| HK40012307A | Optimizing Therapeutic Options In Personalized Medicine |
| KR1020200036022A | Drug Combinations For Targeting Multiple Mutations In Cancer |
| US20200362418A1 | Method Of Prediction Of Tumor-Derived Neo-Peptide Antigenicity And/Or Immunogenicity Using Mutational Signature Patterns |
| US20200237764A1 | Drug Combinations For Targeting Multiple Mutations In Cancer |
| EP3691676A4 | Method Of Prediction Of Tumor-Derived Neo-Peptide Antigenicity And/Or Immunogenicity Using Mutational Signature Patterns |
| EP3665302A4 | Drug Combinations For Targeting Multiple Mutations In Cancer |
| WO2019070769A1 | Method Of Prediction Of Tumor-Derived Neo-Peptide Antigenicity And/Or Immunogenicity Using Mutational Signature Patterns |
| WO2019033123A1 | Drug Combinations For Targeting Multiple Mutations In Cancer |
| WO2018049250A1 | Optimizing Therapeutic Options In Personalized Medicine |
| JP2020530498A | Drug Combinations Targeting Multiple Mutations In Cancer |
What are CureMatch key innovation segments?
What Technologies are Covered by CureMatch?
The chart below distributes patents filed by CureMatch